Editas Medicine, Inc. (44)

Browse by Contract Category

Contracts

Amendment to RSU Agreement, dated May 24, 2022, between the Registrant and James C. Mullen (Filed With SEC on August 3, 2022)
Employment Offer Letter, dated June 14, 2022, between the Registrant and Baisong Mei (Filed With SEC on August 3, 2022)
License Agreement, dated October 10, 2014, between the Registrant and Duke University (Filed With SEC on November 9, 2021)
License and Collaboration Agreement, dated May 26, 2015, between the Registrant and Juno Therapeutics, Inc (Filed With SEC on November 9, 2021)
Common Stock Sales Agreement, dated as of May 14, 2021, by and between the Company and Cowen and Company, LLC (Filed With SEC on May 14, 2021)
Amendment to Employment Offer Letter, dated April 13, 2022, between the Registrant and James C. Mullen (Filed With SEC on August 3, 2022)
Employment Offer Letter, dated April 13, 2022, between the Registrant and Gilmore ONeill (Filed With SEC on August 3, 2022)
Amended Severance Benefits Plan (Filed With SEC on February 24, 2022)
Employment Offer Letter, dated September 22, 2021, between the Registrant and Bruce Eaton (Filed With SEC on November 9, 2021)
License Agreement, dated August 29, 2014, between the Registrant and The General Hospital Corporation, d/b/a Massachusetts General Hospital (Filed With SEC on November 9, 2021)
Second Amendment to the Exclusive Patent License Agreement, by and between the Company and The General Hospital Corporation, d/b/a Massachusetts General Hospital, dated November... (Filed With SEC on November 9, 2021)
Letter Agreement, dated October 9, 2015, between the Registrant and Duke University (Filed With SEC on November 9, 2021)
License Agreement, dated October 29, 2014, among the Registrant, the President and Fellows of Harvard College, and the Broad Institute, Inc (Filed With SEC on November 9, 2021)
Summary of Non-Employee Director Compensation Program (Filed With SEC on August 5, 2021)
Employment Offer Letter, dated April 19, 2021, between the Registrant and Mark S. Shearman (Filed With SEC on August 5, 2021)
Letter Agreement, dated February 15, 2021, by and between the Registrant and Cynthia Collins (Filed With SEC on February 26, 2021)
Omnibus Amendment, dated as of January 11, 2021, by and between the Registrant and Broad (Filed With SEC on February 26, 2021)
Summary of Director Compensation Program (Filed With SEC on February 26, 2021)
First Amendment to Sponsored Research Agreement, dated January 11, 2021, between the Registrant and Broad (Filed With SEC on February 26, 2021)
Employment Offer Letter, dated September 25, 2020, between the Registrant and Lisa A. Michaels, M.D (Filed With SEC on February 26, 2021)
Employment Offer Letter, dated February 14, 2021, between the Registrant and James C. Mullen (Filed With SEC on February 26, 2021)
Underwriting Agreement, dated January 20, 2021, by and among the Company, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC (Filed With SEC on January 21, 2021)
Termination Agreement, dated August 5, 2020, by and between the Company and Allergan Sales, LLC (Filed With SEC on November 6, 2020)
Advisory Services Agreement, Dated May 1, 2020, by and between the Company and Judith Abrams (Filed With SEC on August 7, 2020)
Separation Agreement, dated as of April 30, 2020, by and between the Company and Judith Abrams (Filed With SEC on August 7, 2020)
Underwriting Agreement, dated June 23, 2020, by and between the Company and the Underwriter (Filed With SEC on June 25, 2020)
Common Stock Sales Agreement, dated as of May 15, 2020, by and between the Company and Cowen (Filed With SEC on May 15, 2020)
Amended Severance Benefits Plan (Filed With SEC on February 26, 2020)
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 26, 2020)
Employment Offer Letter, dated October 11, 2019, between the Registrant and Judith R. Abrams, M.D (Filed With SEC on February 26, 2020)
Employment Offer Letter, dated December 27, 2019, between the Registrant and Michelle Robertson (Filed With SEC on February 26, 2020)
Form of Inducement Stock Option Agreement for the Registrants executive officers (Filed With SEC on February 26, 2020)
Form of Inducement Restricted Stock Unit Award Agreement for the Registrants executive officers (Filed With SEC on February 26, 2020)
Letter Agreement, dated as of November 18, 2019, by and among, the Registrant, Broad and Harvard (Filed With SEC on February 26, 2020)
Letter Agreement, dated as of December 16, 2019, by and among, the Registrant, Broad and Harvard (Filed With SEC on February 26, 2020)
Second Amended and Restated License and Collaboration Agreement, dated November 11, 2019, between the Registrant and Juno Therapeutics, Inc. (Juno) (Filed With SEC on February 26, 2020)
License and Agreement, dated November 11, 2019, between the Registrant and Juno (Filed With SEC on February 26, 2020)
Letter Agreement, dated September 26, 2019, by and between the Registrant and Vic Myer, Ph.D (Filed With SEC on November 12, 2019)
Offer Letter, dated August 6, 2019, by and between the Registrant and Cynthia Collins (Filed With SEC on November 12, 2019)
Consulting Agreement, dated January 20, 2019, by and between the Registrant and Cynthia Collins (Filed With SEC on May 8, 2019)
Co-Development and Commercialization Agreement, dated February 22, 2019, by and between the Registrant and Allergan Sales, LLC (Filed With SEC on May 8, 2019)
Letter Agreement, dated January 19, 2019, by and between the Registrant and Katrine Bosley (Filed With SEC on May 8, 2019)
Separation Agreement, by and between the Registrant and Gerald Cox, M.D., Ph.D (Filed With SEC on March 1, 2019)
Form of Restricted Stock Unit Award Agreement under 2015 Stock Incentive Plan (Filed With SEC on January 22, 2019)